Dr. Kurt R. Oettel, MD
Hematology & Oncology (Hematology & Oncology Physician)
- Medicare participating
At a glance
- Years since graduation
- 31
- In the NPI registry since
- 2005
- Medicare patients seen, 2024
- 208
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 2005Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Medicare’s Care Compare data doesn’t list this clinician’s medical school. Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Hematology & Oncology Physician primary
WI license 40041 · IA license 36296
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Gundersen Lutheran Medical Center La Crosse, WI
- Tomah Memorial Hospital Tomah, WI
- Winnmed Decorah, IA
- Gundersen St Josephs Hospital and Clinics Hillsboro, WI
- Black River Memorial Hospital Black River Falls, WI
Medical groups
- Gundersen Lutheran Medical Center Inc (895 clinicians)
- Gundersen Clinic LTD (418 clinicians)
- Saint Elizabeths Hospital of Wabasha Inc (94 clinicians)
- St Josephs Health Services Inc (81 clinicians)
- Tri-County Memorial Hospital Inc (74 clinicians)
- Black River Health Inc (60 clinicians)
- Gundersen Regional Clinics, LLC (53 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 208
- Services billed
- 1,383
- Patients’ average age
- 72
| Service | Times | Patients |
|---|---|---|
| Established patient office or other outpatient visit, 30-39 minutes | 188 | 113 |
| Established patient office or other outpatient visit, 40-54 minutes | 142 | 69 |
| Insertion of needle into vein for collection of blood sample | 37 | 26 |
| Blood creatinine level | 34 | 23 |
| Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | 33 | 22 |
| Blood potassium level | 33 | 23 |
| Blood sodium level | 33 | 23 |
| Urea nitrogen level to assess kidney function, quantitative | 33 | 23 |
| Liver enzyme (sgot), level | 31 | 21 |
| Bilirubin level, total | 31 | 21 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Prednisone Other prescribers in La Crosse, WI | 107 |
| Ondansetron Hcl Other prescribers in La Crosse, WI | 104 |
| Dexamethasone Other prescribers in La Crosse, WI | 102 |
| Prochlorperazine Maleate Other prescribers in La Crosse, WI | 63 |
| Tamoxifen Citrate Other prescribers in La Crosse, WI | 60 |
| Anastrozole Other prescribers in La Crosse, WI | 56 |
| Abiraterone Acetate | 42 |
| Hydrocodone-Acetaminophen (hydrocodone/acetaminophen) Other prescribers in La Crosse, WI | 39 |
| Eliquis (apixaban) Other prescribers in La Crosse, WI | 37 |
| Potassium Chloride Other prescribers in La Crosse, WI | 36 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Industry-funded research
Named as a principal investigator on 2 industry-funded studies in 2025, from 2 companies. The companies reported $83,207 in research payments for these studies, mostly to the institutions running them.
- A Phase 2 Study of Futibatinib in Combination With PD-1 Antibody-based Standard of Care Therapy in Patients With Solid Tumors.
Taiho Oncology, Inc. - A Phase 2, open-label, randomized trial evaluating the impact of enhanced versus standard dermatologic management on selected dermatologic adverse events among patients with locally advanced or metastatic EGFR-mutated…
Janssen Research & Development, LLC
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.